XML 64 R47.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF BUSINESS (Details Narrative)
€ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2022
USD ($)
Nov. 04, 2022
shares
Nov. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2022
EUR (€)
Nov. 14, 2022
Aug. 31, 2022
Awarded grants | €           € 18    
Accumulated deficit       $ 121,261 $ 106,372      
Net cash used in operating activities       $ 24,924 $ 26,866      
MM OS Holdings LP [Member]                
Business combination equity purchase amount     $ 10,000          
Class A Preferred Unit [Member] | Morgenesis LLC [Member]                
Purchase price $ 20,000   30,200          
Class A Preferred Unit [Member] | MM OS Holdings LP [Member]                
Debt conversion amount     10,200          
Business combination equity purchase amount     $ 20,000          
Purchase Agreement [Member] | Class A Preferred Stock [Member]                
Purchase of shares | shares   3,019,651 3,019,651          
Morgenesis LLC [Member]                
Equity method investment, ownership percentage             77.69% 76.90%
Morgenesis [Member] | Purchase Agreement [Member] | Class A Preferred Stock [Member]                
Equity method investment, ownership percentage 22.31% 22.31% 22.31%          
Orgensis Korea Co Ltd [Member] | Cure Cell Co Ltd [Member]                
Equity method investment, ownership percentage       94.12%   94.12%